BIMI Holdings Inc. (BIMI)
Market Cap | 118.67K |
Revenue (ttm) | 12.63M |
Net Income (ttm) | -10.51M |
Shares Out | 13.96M |
EPS (ttm) | -2.29 |
PE Ratio | n/a |
Forward PE | n/a |
Dividend | n/a |
Ex-Dividend Date | n/a |
Volume | 300 |
Open | 0.0100 |
Previous Close | 0.0100 |
Day's Range | 0.0100 - 0.0100 |
52-Week Range | 0.0100 - 4.1300 |
Beta | 1.70 |
Analysts | n/a |
Price Target | n/a |
Earnings Date | Mar 24, 2025 |
About BIMI Holdings
BIMI Holdings Inc., together with its subsidiaries, engages in the retail and wholesale distribution of medical devices, and pharmaceutical and other healthcare products in the People’s Republic of China. The company operates in four segments: Wholesale Pharmaceuticals, Wholesale Medical Devices, Medical Services, and Retail Pharmacies. It distributes Stryker spinal products, Olympus endoscopes, imported imaging products, and diagnostic imaging equipment to drug stores, private clinics, pharmaceutical dealers, and hospitals in the Southwest reg... [Read more]
Financial Performance
In 2022, BIMI Holdings's revenue was $11.83 million, a decrease of -44.51% compared to the previous year's $21.32 million. Losses were -$22.39 million, -35.99% less than in 2021.
Financial StatementsNews
BIMI Announces Receipt of a Delinquency Compliance Alert Notice from Nasdaq
New York, May 20, 2024 (GLOBE NEWSWIRE) -- BIMI Holdings Inc. (NASDAQ: BIMI) (“BIMI” or the “Company”), previously known as BIMI International Medical Inc., a healthcare products and services provider...
BIMI Announces Results of 2023 Annual General Meeting of Stockholders
New York, Jan. 03, 2024 (GLOBE NEWSWIRE) -- BIMI Holdings Inc. (NASDAQ: BIMI) (“BIMI” or the “Company”), previously known as (BIMI International Medical Inc.) a healthcare products and services provid...
BIMI International Medical Inc. Announces Third Quarter 2023 Financial Results
NEW YORK, Dec. 19, 2023 (GLOBE NEWSWIRE) -- BIMI International Medical Inc. (the “Company”), a leading medical solutions provider, today announced its financial results for the three months and nine ...
BIMI Announces Buyback of Warrants
NEW YORK, NY, Nov. 28, 2023 (GLOBE NEWSWIRE) -- BIMI International Medical Inc. (NASDAQ: BIMI, "BIMI"), a healthcare products and services provider, today announced its entry into material definitive ...
BIMI International Medical Inc. Announces Second Quarter 2023 Financial Results
NEW YORK, Nov. 27, 2023 (GLOBE NEWSWIRE) -- BIMI International Medical Inc. (the “Company”), a leading medical solutions provider, today announced its financial results for the three months ended June...
BIMI Receives Nasdaq Notification of Non-Compliance with Listing Rule 5250(c)(1)
NEW YORK, Nov. 27, 2023 (GLOBE NEWSWIRE) -- BIMI International Medical Inc. (the “Company”) today announced that on November 21, 2023, the Company received a notification letter from The Nasdaq Stock...
BIMI Announces Subsidiary Phenix Bio Inc.'s New Product Launch
NEW YORK, NY, Nov. 08, 2023 (GLOBE NEWSWIRE) -- Phenix Bio Inc., a wholly owned subsidiary of BIMI International Medical Inc. (NASDAQ: BIMI), a leading global healthcare provider, announces the offici...
BIMI International Medical Inc. Announces Subsidiary Phenix Bio Inc's Appointment of Hong Kong, Taiwan, and Macau Exclusive Distributor
NEW YORK, NY, Oct. 30, 2023 (GLOBE NEWSWIRE) -- BIMI International Medical Inc. (NASDAQ: BIMI, “BIMI”), a healthcare products and services provider today announced that its subsidiary, Phenix Bio Inc....
BIMI International Medical Inc. Announces Subsidiary Phenix Bio Inc's Appointment of Mainland China Non-Exclusive Distributor
NEW YORK, NY, Oct. 30, 2023 (GLOBE NEWSWIRE) -- BIMI International Medical Inc. (NASDAQ: BIMI, “BIMI”), a healthcare products and services provider today announced that its subsidiary, Phenix Bio Inc....
BIMI International Medical Inc. Announces Subsidiary Phenix Bio Inc's Appointment of ASEAN Exclusive Distributor
NEW YORK, NY, Sept. 22, 2023 (GLOBE NEWSWIRE) -- BIMI International Medical Inc. (NASDAQ: BIMI, "BIMI"), a healthcare products and services provider today announced its subsidiary, Phenix Bio Inc., ap...
BIMI International Medical Inc. Announces Strategic Partnership by its Phenix Bio Inc. Subsidiary with China Duty Free Group
NEW YORK, NY, Aug. 07, 2023 (GLOBE NEWSWIRE) -- BIMI International Medical Inc. (NASDAQ: BIMI, “BIMI”), a leading global provider of healthcare services and innovative medical solutions, today announc...
BIMI International Medical Inc. Announces First Quarter 2023 Financial Results
NEW YORK, May 22, 2023 (GLOBE NEWSWIRE) -- BIMI International Medical Inc. (the “Company”), a leading medical solutions provider, today announced its financial results for the three months ended March...
BIMI Announces Results of 2023 Special meeting of Shareholders.
NEW YORK, April 19, 2023 (GLOBE NEWSWIRE) -- BIMI International Medical Inc. (NASDAQ: BIMI) (“BIMI” or the “Company”), a healthcare products and services provider, today announced the results of the C...
BIMI Announces Entry into a Material Definitive Agreement
NEW YORK, Dec. 13, 2022 (GLOBE NEWSWIRE) -- BIMI International Medical Inc. (NASDAQ: BIMI) (“BIMI” or the “Company”), a healthcare products and services provider, today announced its entry into an Ame...
BIMI Announces Sale of $2 Million Promissory Note
NEW YORK, Dec. 08, 2022 (GLOBE NEWSWIRE) -- BIMI International Medical Inc. (NASDAQ: BIMI) (“BIMI” or the “Company”), a healthcare products and services provider, today announced the sale of a $2 Mi...
BIMI Announces 1-for -10 Reverse Stock Split
BIMI intends to use a reverse-stock split to bring the company into compliance with listing requirements of The Nasdaq Capital Market.
BIMI Announces Second Quarter 2022 Financial Results
NEW YORK, Aug. 22, 2022 (GLOBE NEWSWIRE) -- BIMI International Medical Inc. (NASDAQ: BIMI) (“BIMI” or the “Company”), a healthcare products and services provider, today announced its financial results...
BIMI Announces Results of 2022 Annual General Meeting of Stockholders
New York, July 15, 2022 (GLOBE NEWSWIRE) -- BIMI International Medical Inc. (NASDAQ: BIMI) (“BIMI” or the “Company”), a healthcare products and services provider, today announced the results of the Co...
BIMI Enters into Definitive Agreement to Acquire Phenix Bio Inc.
Transaction expected to expand business and fuel growth
BIMI to Hold Annual Shareholder Meeting on July 13, 2022
BIMI International Medical Inc. (NASDAQ: BIMI) (“BIMI” or the “Company”), a healthcare products and services provider, announced that it will hold its annual meeting of shareholders on July 13, 2022 a...
Why BIMI International Medical Shares Are Trading Higher Today
Shares of small-cap penny stock BIMI International Medical Inc. (NASDAQ: BIMI) shares are trading higher after the company announced it entered a $5 million stock purchase agreement with chairman Fnu ...
BIMI Announces Entering into a $5 million Stock Purchase Agreement
NEW YORK, June 10, 2022 (GLOBE NEWSWIRE) -- BIMI International Medical Inc. (NASDAQ: BIMI) (“BIMI” or the “Company”), a healthcare products and services provider, today announced that on June 9, 2022,...
BIMI International Medical Announces First Quarter 2022 Financial Results
NEW YORK, May 20, 2022 (GLOBE NEWSWIRE) -- BIMI International Medical Inc. (NASDAQ: BIMI) (“BIMI” or the “Company”), a healthcare products and services provider, today announced its financial results ...
BIMI Announces Appointment of New Chairman and Independent Director
NEW YORK, May 18, 2022 (GLOBE NEWSWIRE) -- BIMI International Medical Inc. (NASDAQ: BIMI) (“BIMI” or the “Company”), a healthcare products and services provider, today announced that on May 12, 2022, ...
BIMI Announces Appointment of Mr. Fnu Oudom to Board of Directors
NEW YORK, May 12, 2022 (GLOBE NEWSWIRE) -- BIMI International Medical Inc. (NASDAQ: BIMI) (“BIMI” or the “Company”), a healthcare products and services provider, today announced that it has appointed ...